Sanjeev Krishna

Active 1983–2025

112
Papers
19,148
Citations
78
h-index
109
i10-index

Citations

Citations per year for Sanjeev Krishna1971: 1 citations1981: 1 citations1985: 2 citations1987: 4 citations1988: 5 citations1989: 5 citations1990: 6 citations1991: 3 citations1992: 14 citations1993: 2 citations1994: 7 citations1995: 5 citations1996: 34 citations1997: 22 citations1998: 24 citations1999: 20 citations2000: 53 citations2001: 47 citations2002: 60 citations2003: 92 citations2004: 135 citations2005: 214 citations2006: 251 citations2007: 248 citations2008: 251 citations2009: 281 citations2010: 270 citations2011: 222 citations2012: 160 citations2013: 198 citations2014: 161 citations2015: 149 citations2016: 157 citations2017: 138 citations2018: 146 citations2019: 400 citations2020: 537 citations2021: 563 citations2022: 453 citations2023: 268 citations2024: 304 citations2025: 130 citations1972–1980: no citations, so these years are not shown1982–1984: no citations, so these years are not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,675 citing papers, 18.1% of this breakdownUnited Kingdom: 997 citing papers, 10.8% of this breakdownChina: 542 citing papers, 5.8% of this breakdownGermany: 450 citing papers, 4.9% of this breakdownAustralia: 351 citing papers, 3.8% of this breakdownFrance: 340 citing papers, 3.7% of this breakdownSwitzerland: 316 citing papers, 3.4% of this breakdownIndia: 280 citing papers, 3% of this breakdownThailand: 258 citing papers, 2.8% of this breakdownCanada: 257 citing papers, 2.8% of this breakdownItaly: 235 citing papers, 2.5% of this breakdownNetherlands: 181 citing papers, 1.9% of this breakdown
0%18.1%Other 36.5%

Fields

  • Medicine63.7%
  • Biochemistry, Genetics and Molecular Biology17.5%
  • Immunology and Microbiology4%
  • Neuroscience3.2%
  • Agricultural and Biological Sciences2.2%
  • Computer Science1.7%
  • Other7.7%

Topics

  • Malaria Research and Control12.2%
  • Mosquito-borne diseases and control4.9%
  • Computational Drug Discovery Methods4.6%
  • COVID-19 Clinical Research Studies2.7%
  • SARS-CoV-2 and COVID-19 Research2.4%
  • Trypanosoma species research and implications2.1%
  • Other71.1%

Coauthors

All papers

Open in search
  1. A living WHO guideline on drugs for covid-19 (2020-2023)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Muhammad Mohsin Haider, Matthias Götte, Nerina Harley, Madiha Hashmi, David S.C. Hui, Mohamed Ismail, Fyezah Jehan, Sushil Kumar Kabra, Seema Kanda, Yae‐Jean Kim, Niranjan Kissoo, Sanjeev Krishna, Krutika Kuppalli, Arthur Kwizera, Marta Lado Castro-Rial, Thiago Lisboa, Rakesh Lodha, Imelda Mahaka, Hela Manai, Marc Mendelson, Giovanni Battista Migliori, G Miño, Emmanuel Nsutebu, Jessica Peter, Jacobus Preller, N. Pshenichnaya, Nida Qadir, Shalini Sri Ranganathan, Pryanka Relan, Jamie Rylance, Saniya Sabzwari, Rohit Sarin, Manu Shankar‐Hari, Michael Sharland, Yinzhong Shen, João Paulo Souza, Ronald Swanstrom, Tshokey Tshokey, Sebastián Ugarte, Timothy M. Uyeki, Evangelina Vázquez Curiel, Sridhar Venkatapuram, Dubula Vuyiseka, Ananda Wijewickrama, Lien Tran, Dena Zeraatkar, Jessica J Bartoszko, Long Ge, Romina Brignardello‐Petersen, Andrew Owen, Gordon Guyatt, Janet Dı́az, Letícia Kawano-Dourado, Michael Jacobs, Per Olav Vandvik - BMJ 2020 cited by 1,089

  2. Structural classification of zinc fingers: SURVEY AND SUMMARY

    Authors: - Nucleic Acids Research 2003 cited by 926

  3. Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema

    Authors: , , , - The FASEB Journal 2004 cited by 758

  4. Molecular mechanisms of brain tumor edema

    Authors: , , , , , - Neuroscience 2004 cited by 301

  5. A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer

    Authors: , , , , , , , , , , - EBioMedicine 2014 cited by 213

  6. Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing

    Authors: , , - Pharmacology & Therapeutics 2020 cited by 113

  7. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

    Authors: , , , , , , , , , , , - The Lancet 2004 cited by 839

  8. Host genetic factors determining COVID-19 susceptibility and severity

    Authors: , , , , , , - EBioMedicine 2021 cited by 239

  9. Artemisinins: their growing importance in medicine

    Authors: , , , - Trends in Pharmacological Sciences 2008 cited by 387

  10. Decreasingpfmdr1Copy Number inPlasmodium falciparumMalaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and Artemisinin

    Authors: , , , , , - The Journal of Infectious Diseases 2006 cited by 407

  11. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bertrand Lell, Barbara Lemaître, Ansgar W. Lohse, Marguerite Massinga Loembé, Alain Matthey, Benjamin Mordmüller, Anne Nolting, Caroline Ogwang, Michael Ramharter, Jonas Schmidt‐Chanasit, Stefan Schmiedel, Peter Silvera, Felix R. Stahl, Henry M. Staines, Thomas Strecker, Hans Stubbe, Benjamin Tsofa, Sherif R. Zaki, Patricia Fast, Vasee Moorthy, Laurent Kaiser, Sanjeev Krishna, Stephan Becker, Marie-Paule Kiény, Philip Bejon, Peter G. Kremsner, Marylyn M. Addo, Claire‐Anne Siegrist - New England Journal of Medicine 2015 cited by 413

  12. Multi-omics dissection of stage-specific artemisinin tolerance mechanisms in Kelch13-mutant Plasmodium falciparum

    Authors: , , , , , , , , , , , , , - Drug Resistance Updates 2023 cited by 21

  13. A Temporizing Solution to “Artemisinin Resistance”

    Authors: , , , , , - New England Journal of Medicine 2019 cited by 88

  14. A living WHO guideline on drugs to prevent covid-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Seema Kanda, Letícia Kawano-Dourado, Yae‐Jean Kim, Niranjan Kissoon, Sanjeev Krishna, Arthur Kwizera, Thiago Lisboa, Yee‐Sin Leo, Imelda Mahaka, Hela Manai, Giovanni Battista Migliori, G Miño, Emmanuel Nsutebu, N. Pshenichnaya, Nida Qadir, Shalini Sri Ranganathan, Saniya Sabzwari, Rohit Sarin, Manu Shankar‐Hari, Michael Sharland, Yinzhong Shen, João Paulo Souza, Tshokey Tshokey, Sebastián Ugarte, Tim Uyeki, Sridhar Venkatapuram, Ablo Prudence Wachinou, Ananda Wijewickrama, Dubula Vuyiseka, Jacobus Preller, Romina Brignardello‐Petersen, Elena Kum, Anila Qasim, Dena Zeraatkar, Andrew Owen, Gordon Guyatt, Lyubov Lytvyn, Michael Jacobs, Per Olav Vandvik, Janet Dı́az - BMJ 2021 cited by 150

  15. Maternal nutritional risk factors for pre-eclampsia incidence: findings from a narrative scoping review

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eusébio Macete, Carla Carillho, Lazaro Quimice, Sónia Maculuve, Donna Russell, Ben Baratt, Joy E Lawn, Hannah Blencowe, Véronique Filippi, Matt J. Silver, Prestige Tatenda Makanga, Liberty Makacha, Yolisa Prudence Dube, Newton Nyapwere, Reason Mlambo, Umberto D’Alessandro, Anna Roca, Melisa Martínez-Álvarez, Hawanatu Jah, Brahima A. Diallo, Abdul Karim Sesay, Fatima Touray, Abdoulie Sillah, J. Alison Noble, Aris T. Papageorghiou, Judith E. Cartwright, Guy Whitley, Sanjeev Krishna, Rosemarie Townsend, Asma Khalil, Marianne Vidler, Joel Singer, Jing Li, Jeffrey N. Bone, Mai‐Lei Woo Kinshella, Kelly Pickerill, Ash Sandhu, Tu Domena, Rajavel Elango, William Stones - Reproductive Health 2022 cited by 45

  16. Artemisinins target the SERCA of Plasmodium falciparum

    Authors: , , , , , , , , , - Nature 2003 cited by 1,023

  17. The trypanosomiases

    Authors: , , , , , , - The Lancet 2003 cited by 654

  18. Molecular assays for antimalarial drug resistance surveillance: A target product profile

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2018 cited by 52

  19. Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2006 cited by 317

  20. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa

    Authors: , , , , , , , - Tropical Medicine & International Health 2007 cited by 171

  21. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 145

  22. Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rodolphe Thiébaut, Marcus Altfeld, Marylyn M. Addo - Cell Reports 2017 cited by 125

  23. A Brief Illustrated Guide to the Ultrastructure of Plasmodium falciparum Asexual Blood Stages

    Authors: , , , , - Parasitology Today 2000 cited by 344

  24. Intraerythrocytic Plasmodium falciparum Expresses a High Affinity Facilitative Hexose Transporter

    Authors: , , - Journal of Biological Chemistry 1999 cited by 144